Valentine Capital Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Valentine Capital Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$3K	Sell	24 -24,443	-100%	-$3.39M	﹤0.01%	173
2015 Q3	$3.25M	Buy	24,467 +2,227	+10%	+$383K	2.87%	6
2015 Q2	$3.92M	Sell	22,240 -19,386	-47%	-$3.48M	2.63%	6
2015 Q1	$7.19M	Sell	41,626 -15,201	-27%	-$2.61M	2.1%	10
2014 Q4	$9.3M	Buy	+56,827	New	+$9.43M	2.26%	5
2014 Q3	–	Sell	-79,326	Closed	-$11.7M	–	83
2014 Q2	$11.7M	Sell	79,326 -5,599	-7%	-$776K	2.24%	5
2014 Q1	$11.8M	Buy	84,925 +1,417	+2%	+$213K	2.44%	6
2013 Q4	$10.6M	Sell	83,508 -59,091	-41%	-$6.11M	2.26%	9
2013 Q3	$13.1M	Buy	142,599 +2,405	+2%	+$194K	3.43%	2
2013 Q2	$9.64M	Buy	+140,194	New	+$8.57M	3.01%	5

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

Valentine Capital Asset Management's JAZZ Position: Q4 2015 in Review

Valentine Capital Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 100% in Q4 2015, selling an estimated $3.39M and leaving 24 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Valentine Capital Asset Management first reported a position in JAZZ in Q2 2013 and has held it in 10 quarters since. The position peaked at $13.1M in Q3 2013. 346 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

Valentine Capital Asset Management held 24 shares of Jazz Pharmaceuticals worth $3K as of Q4 2015.
Valentine Capital Asset Management sold 24,443 Jazz Pharmaceuticals shares in Q4 2015, an estimated $3.39M.
Jazz Pharmaceuticals made up ﹤0.01% of Valentine Capital Asset Management's portfolio in Q4 2015, its #173 holding.
Valentine Capital Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Valentine Capital Asset Management's Jazz Pharmaceuticals position peaked at $13.1M in Q3 2013.
346 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.